These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 9610709

  • 1. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390).
    Forastiere AA, Shank D, Neuberg D, Taylor SG, DeConti RC, Adams G.
    Cancer; 1998 Jun 01; 82(11):2270-4. PubMed ID: 9610709
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA, Ilson DH, Kelsen DP.
    Semin Oncol; 1996 Oct 01; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [Abstract] [Full Text] [Related]

  • 3. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
    Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J, Forastiere AA, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2005 May 20; 23(15):3562-7. PubMed ID: 15908667
    [Abstract] [Full Text] [Related]

  • 4. A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma.
    Steinberg L, Hassan M, Olmsted L, Sharan V, Stepnick D, Hoppel C, Mugharbil A, Subramanyan S, McGloin B, Mackay W, Strauss M.
    Semin Oncol; 1997 Dec 20; 24(6 Suppl 19):S19-51-S19-56. PubMed ID: 9427267
    [Abstract] [Full Text] [Related]

  • 5. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Ginsberg L, Lawhorn K, Hong WK, Lippman SM.
    Semin Oncol; 1997 Dec 20; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK.
    Cancer; 2002 Jul 15; 95(2):322-30. PubMed ID: 12124833
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
    Adamo V, Ferraro G, Pergolizzi S, Sergi C, Laudani A, Settineri N, Alafaci E, Scimone A, Spano F, Spitaleri G.
    Oral Oncol; 2004 May 15; 40(5):525-31. PubMed ID: 15006626
    [Abstract] [Full Text] [Related]

  • 8. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
    Hussain M, Gadgeel S, Kucuk O, Du W, Salwen W, Ensley J.
    Cancer; 1999 Dec 01; 86(11):2364-9. PubMed ID: 10590379
    [Abstract] [Full Text] [Related]

  • 9. Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer.
    Forastiere AA, Urba SG.
    Semin Oncol; 1995 Jun 01; 22(3 Suppl 6):24-7. PubMed ID: 7597431
    [Abstract] [Full Text] [Related]

  • 10. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP, Moon J, Samlowski W, Clark JI, Dakhil SR, Williamson S, Urba SG, Ensley J, Hussain MH, Southwest Oncology Group, Head and Neck Working Group.
    Cancer; 2006 Jul 15; 107(2):319-27. PubMed ID: 16779801
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH, Forastiere A, Arquette M, Costa F, Heelan R, Huang Y, Kelsen DP.
    Cancer J; 2000 Jul 15; 6(5):316-23. PubMed ID: 11079171
    [Abstract] [Full Text] [Related]

  • 14. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct 15; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW.
    Cancer; 2002 Apr 15; 94(8):2224-31. PubMed ID: 12001121
    [Abstract] [Full Text] [Related]

  • 18. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M, Jaboin J, Taylor R, Wolf J, Banglore M, Van Echo D, Ord R.
    Semin Oncol; 2004 Dec 15; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [Abstract] [Full Text] [Related]

  • 19. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
    Schena M, Barone C, Birocco N, Dongiovanni D, Numico G, Colantonio I, Bertetto O.
    Cancer Chemother Pharmacol; 2005 Mar 15; 55(3):271-6. PubMed ID: 15592837
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.